88R HB 235
by Rep. Howard, same lead author · Died in committee · same text
Introduced textLast action, Feb 23, 2023: Referred to Public Health
Relating to the authority of pharmacists to furnish certain medications.
Caption, 88R bill history
HB 845
Died in committee
Initial review · graded Oct 20, 2026 · Headline, summary and grade are analysis of the bill text, not a finding about any person · How we grade
relating to the authority of pharmacists to furnish certain medications.
Caption from analyzed text · version I.
Rapid test at the pharmacy, physician’s written protocol required.
The bill lets a trained pharmacist give a patient a prescription drug for strep throat or flu after a rapid test at the pharmacy, as long as a physician's written protocol covers it. It touches pharmacists, physicians who sign the protocols, patients, and the state pharmacy and medical boards, which must write joint rules on the protocols and the required training by January 1, 2026. On the ground, a patient could get tested and treated at a pharmacy without an existing doctor relationship, and the pharmacist must notify the patient's primary care doctor within 14 days.
Labels: ZOMBIE BILL. Died 2 times: 88R HB 235 (Died in committee) and this bill (Died in committee). Checked against 88R only.BACK FROM THE DEAD. Same text as a bill filed before that died: 88R HB 235 (Died in committee). Filed in 2 sessions, counting this one. Checked against 88R only.TRY NO. 2. Filed in 2 sessions: 88R and 89R. Checked against 88R only.NEVER GOT A HEARING. Filed Nov 12, 2024 and referred to the House Public Health committee. No public hearing. The bill died.
89R-HB845 · 2024-11-12
relating to the authority of pharmacists to furnish certain medications.
Rapid test at the pharmacy, physician’s written protocol required.
The bill lets a trained pharmacist give a patient a prescription drug for strep throat or flu after a rapid test at the pharmacy, as long as a physician's written protocol covers it. It touches pharmacists, physicians who sign the protocols, patients, and the state pharmacy and medical boards, which must write joint rules on the protocols and the required training by January 1, 2026. On the ground, a patient could get tested and treated at a pharmacy without an existing doctor relationship, and the pharmacist must notify the patient's primary care doctor within 14 days.
[ ] NONE FOUND
No fiscal note in the loaded record.
No verified beat found.
THANK YOU FOR CHECKING THE RECEIPT
CAMPAIGN PAID FOR BY
Not tied to this bill.
The author's campaign account only. Own money and internal transfers are separate on the member page.
Derived itemized flow · Oct 28, 2024 to Oct 24, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
$15,000.00
Also funds 137 other sitting lawmakers.
Derived recipient stock · Jul 24, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.
TEC account match.
TeamDerived itemized flow · Dec 10, 2024 to Oct 2, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 100985297, 101031291, 101059636, 101070104.
$7,500.00
Also funds 38 other sitting lawmakers.
Derived recipient stock · Nov 19, 2024 to Oct 5, 2026. State data as of Nov 4, 2026.
TEC account match.
TeamDerived itemized flow · Dec 11, 2024 to Sep 12, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 100985297, 101069647.
$7,000.00
Also funds 8 other sitting lawmakers.
Derived recipient stock · Aug 22, 2025 to May 21, 2026. State data as of Nov 4, 2026.
TEC account match.
Derived itemized flow · on May 21, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 101059636.
Missing data does not establish zero giving. Display amounts are rounded.
$15,000.00
Also funds 137 other sitting lawmakers.
Derived recipient stock · Jul 24, 2024 to Oct 23, 2026. State data as of Nov 4, 2026.
TEC account match.
TeamDerived itemized flow · Dec 10, 2024 to Oct 2, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 100985297, 101031291, 101059636, 101070104.
$7,500.00
Also funds 38 other sitting lawmakers.
Derived recipient stock · Nov 19, 2024 to Oct 5, 2026. State data as of Nov 4, 2026.
TEC account match.
TeamDerived itemized flow · Dec 11, 2024 to Sep 12, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 100985297, 101069647.
$7,000.00
Also funds 8 other sitting lawmakers.
Derived recipient stock · Aug 22, 2025 to May 21, 2026. State data as of Nov 4, 2026.
TEC account match.
Derived itemized flow · on May 21, 2026. State data as of Nov 4, 2026.
Derived itemized contributions on live regular reports and uncovered special-session dates. Internal account transfers and daily reports are excluded.
Report IDs: 101059636.
No floor vote loaded for this bill.
No fiscal note in the loaded record.
Analysis of text version I by claude-opus-5-5, Oct 20, 2026, against the published rubric.
Filed 2 times: 88R and 89R. Checked against 88R only.
by Rep. Howard, same lead author · Died in committee · same text
Introduced textLast action, Feb 23, 2023: Referred to Public Health
Relating to the authority of pharmacists to furnish certain medications.
Caption, 88R bill history
Texas House · Filed Nov 12, 2024
03/05/2025 H Referred to Public Health: Mar 5 2025 11:46AM
Texas Legislature Online · Introduced
Data snapshot Oct 26, 2026 at 4:20 AM CDT. Grades, charges, quotes and corrections follow the published record.
House committee · Public Health · Final status: Died in committee
Health--General
Occupational Regulation--Health Occupations
MEDICINE & PRESCRIPTION DRUGS
PHARMACIES & PHARMACISTS
MEDICAL BOARD, TEXAS
PHARMACY, TEXAS STATE BOARD OF
The text as introduced · 893 words
89R3302 RAL-F By: Howard H.B. No. 845 A BILL TO BE ENTITLED AN ACT relating to the authority of pharmacists to furnish certain medications. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: SECTION 1. Section 483.001(11), Health and Safety Code, is amended to read as follows: (11) "Practice of pharmacy" has the meaning assigned by Section 551.003, Occupations Code [ means: [ (A) provision of those acts or services necessary to provide pharmaceutical care; [ (B) interpretation and evaluation of prescription drug orders or medication orders; [ (C) participation in drug and device selection as authorized by law, drug administration, drug regimen review, or drug or drug-related research; [ (D) provision of patient counseling; [ (E) responsibility for: [ (i) dispensing of prescription drug orders or distribution of medication orders in the patient's best interest; [ (ii) compounding and labeling of drugs and devices, except labeling by a manufacturer, repackager, or distributor of nonprescription drugs and commercially packaged prescription drugs and devices; [ (iii) proper and safe storage of drugs and devices; or [ (iv) maintenance of proper records for drugs and devices. In this subdivision, "device" has the meaning assigned by Subtitle J, Title 3, Occupations Code; or [ (F) performance of a specific act of drug therapy management for a patient delegated to a pharmacist by a written protocol from a physician licensed by the state under Subtitle B, Title 3, Occupations Code ]. SECTION 2. Subchapter C, Chapter 157, Occupations Code, is amended by adding Section 157.102 to read as follows: Sec. 157.102. DELEGATION TO PHARMACIST TO FURNISH CERTAIN DRUGS. (a) In this section: (1) "Acute condition" means a condition or disease that begins abruptly, intensifies rapidly, and is generally not long-lasting. (2) "Pharmacist" has the meaning assigned by Section 551.003. (3) "Waived clinical laboratory test" means a clinical laboratory test that is classified as waived under federal regulations issued under the Clinical Laboratory Improvement Amendments of 1988 (42 U.S.C. Section 263a). (4) "Written protocol" means a physician's written order, standing medical order, standing delegation order, or other order or protocol as defined by rule of the board. (b) Notwithstanding any other law, a pharmacist may furnish to a patient, as provided by a physician's written protocol, a prescription drug to treat an acute condition that is identified through performance of one of the following tests, if the test is a waived clinical laboratory test: (1) a rapid strep test or rapid antigen detection test used in the identification of group A streptococcus (GAS); or (2) a rapid influenza diagnostic test used in the identification of influenza types A and B. (c) The board shall adopt rules jointly with the Texas State Board of Pharmacy to establish the minimum content of the written protocol required under Subsection (b). The written protocol may permit a pharmacist to furnish a prescription drug to a patient without an established physician-patient relationship. (d) A written protocol under this section must require notice to the patient's primary care physician, as identified by the patient if the patient has a primary care physician, and prescribe the period for providing the notice and the form of the notice, in accordance with prevailing practices for the provision of notice to a patient's primary care physician. The period for providing the notice may not be later than the 14th day after the date the drug is furnished by the pharmacist. SECTION 3. Section 551.003(33), Occupations Code, is amended to read as follows: (33) "Practice of pharmacy" means: (A) providing an act or service necessary to provide pharmaceutical care; (B) interpreting or evaluating a prescription drug order or medication order; (C) participating in drug or device selection as authorized by law, and participating in drug administration, drug regimen review, or drug or drug-related research; (D) providing patient counseling; (E) being responsible for: (i) dispensing a prescription drug order or distributing a medication order; (ii) compounding or labeling a drug or device, other than labeling by a manufacturer, repackager, or distributor of a nonprescription drug or commercially packaged prescription drug or device; (iii) properly and safely storing a drug or device; or (iv) maintaining proper records for a drug or device; (F) performing for a patient a specific act of drug therapy management delegated to a pharmacist by a written protocol from a physician licensed in this state in compliance with Subtitle B; [ or ] (G) administering an immunization or vaccination under a physician's written protocol ; or (H) furnishing a prescription drug to a patient under a physician's written protocol under Section 157.102 . SECTION 4. Subchapter B, Chapter 562, Occupations Code, is amended by adding Section 562.058 to read as follows: Sec. 562.058. TRAINING REQUIRED TO FURNISH CERTAIN DRUGS. (a) A pharmacist may not furnish a prescription drug under Section 157.102 unless the pharmacist has completed a training program that is approved by the board and is relevant to the condition treated by the drug. (b) The board shall adopt rules jointly with the Texas Medical Board to establish the minimum content of the training program required under Subsection (a). SECTION 5. Not later than January 1, 2026, the Texas State Board of Pharmacy and the Texas Medical Board shall adopt the rules required under Sections 157.102 and 562.058, Occupations Code, as added by this Act. SECTION 6. This Act takes effect September 1, 2025.